Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Gomollon

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Crohn'S & Colitis|April 30, 2013
ECCO position statement: the use of biosimilar medicines in the treatment of inflammatory bowel disease (IBD)Silvio Danese, Fernando Gomollon,
Journal of Crohn'S & Colitis|February 12, 2014
EMA response to ECCO position statement on biosimilarsSilvio Danese, Fernando Gomollon, Pierre Michetti
Inflammatory Bowel Diseases|April 14, 2009
Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel diseaseJavier P Gisbert, Adrian G McNicholl, Fernando Gomollon
Nutrients|December 15, 2018
Iron Treatment May Be Difficult in Inflammatory Diseases: Inflammatory Bowel Disease as a ParadigmCarla J Gargallo-Puyuelo, Erika Alfambra, Jose Antonio García-Erce, et al.
Open Research Europe|October 3, 2025
Mechanochemistry in Europe: where we come from and where we are nowJuan José Sáenz de la Torre, Leyre Flamarique, Fernando Gomollon-Bel, et al.
Acta Chimica Slovenica|June 24, 2026
Mehanokemija v Evropi: od kod prihajamo in kje smo danesMirela Dragomir, Tadej Rojac, Juan José Sáenz de la Torre, et al.
Cancers|February 11, 2023
A Point-of-Care Faecal Test Combining Four Biomarkers Allows Avoidance of Normal Colonoscopies and Prioritizes Symptomatic Patients with a High Risk of Colorectal CancerGonzalo Hijos-Mallada, Nuria Saura, Alberto Lué, et al.
Therapeutic Advances in Gastroenterology|June 12, 2020
The combination of quantitative faecal occult blood test and faecal calprotectin is a cost-effective strategy to avoid colonoscopies in symptomatic patients without relevant pathologyAlberto Lué, Gonzalo Hijos, Carlos Sostres, et al.
Journal of Crohn'S & Colitis|December 18, 2014
European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseasesAxel U Dignass, Christoph Gasche, Dominik Bettenworth, et al.
Inflammatory Bowel Diseases|November 7, 2007
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseasesChristoph Gasche, Arnold Berstad, Ragnar Befrits, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Crohn'S & Colitis|April 30, 2013
ECCO position statement: the use of biosimilar medicines in the treatment of inflammatory bowel disease (IBD)Silvio Danese, Fernando Gomollon,
Journal of Crohn'S & Colitis|February 12, 2014
EMA response to ECCO position statement on biosimilarsSilvio Danese, Fernando Gomollon, Pierre Michetti
Inflammatory Bowel Diseases|April 14, 2009
Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel diseaseJavier P Gisbert, Adrian G McNicholl, Fernando Gomollon
Nutrients|December 15, 2018
Iron Treatment May Be Difficult in Inflammatory Diseases: Inflammatory Bowel Disease as a ParadigmCarla J Gargallo-Puyuelo, Erika Alfambra, Jose Antonio García-Erce, et al.
Open Research Europe|October 3, 2025
Mechanochemistry in Europe: where we come from and where we are nowJuan José Sáenz de la Torre, Leyre Flamarique, Fernando Gomollon-Bel, et al.
Acta Chimica Slovenica|June 24, 2026
Mehanokemija v Evropi: od kod prihajamo in kje smo danesMirela Dragomir, Tadej Rojac, Juan José Sáenz de la Torre, et al.
Cancers|February 11, 2023
A Point-of-Care Faecal Test Combining Four Biomarkers Allows Avoidance of Normal Colonoscopies and Prioritizes Symptomatic Patients with a High Risk of Colorectal CancerGonzalo Hijos-Mallada, Nuria Saura, Alberto Lué, et al.
Therapeutic Advances in Gastroenterology|June 12, 2020
The combination of quantitative faecal occult blood test and faecal calprotectin is a cost-effective strategy to avoid colonoscopies in symptomatic patients without relevant pathologyAlberto Lué, Gonzalo Hijos, Carlos Sostres, et al.
Journal of Crohn'S & Colitis|December 18, 2014
European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseasesAxel U Dignass, Christoph Gasche, Dominik Bettenworth, et al.
Inflammatory Bowel Diseases|November 7, 2007
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseasesChristoph Gasche, Arnold Berstad, Ragnar Befrits, et al.
Pageof 2